Gin Hwa Biotech (ROCO:7806) EPS (Basic): NT$3.05 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7806 Gin Hwa Biotech Inc ROCO:7806
22 GF Score
Price NT$61.90
! 2 Warning Signs
View Full Analysis

What is Gin Hwa Biotech EPS (Basic)?

Gin Hwa Biotech ROCO:7806 22 EPS (Basic) is NT$3.05 as of Dec. 2025. GuruFocus rates ROCO:7806 with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

Gin Hwa Biotech's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was NT$1.07. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$3.05.

Gin Hwa Biotech's EPS (Diluted) for the six months ended in Dec. 2025 was NT$1.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$3.04.

Gin Hwa Biotech's EPS without NRI for the six months ended in Dec. 2025 was NT$1.07. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 3.04.

During the past 12 months, Gin Hwa Biotech's average EPS without NRIGrowth Rate was 1.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Gin Hwa Biotech's highest 3-Year average EPS without NRI Growth Rate was 10.10% per year. The lowest was 10.10% per year. And the median was 10.10% per year.

Gin Hwa Biotech  (ROCO:7806) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Gin Hwa Biotech EPS (Basic) Related Terms

Gin Hwa Biotech EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Gin Hwa Biotech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gin Hwa Biotech EPS (Basic) Chart

Gin Hwa Biotech Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EPS (Basic)
2.27 4.34 3.04 3.05

Gin Hwa Biotech Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial 1.89 1.82 1.22 1.99 1.07
ROCO:7806
22GF Score
Gin Hwa Biotech Inc ROCO:7806
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gin Hwa Biotech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Gin Hwa Biotech's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(75.332-0)/24.704
=3.05

Gin Hwa Biotech's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(27.414-0)/25.247
=1.09

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$3.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of NT$3.05 mean?
Gin Hwa Biotech (ROCO:7806) has a EPS (Basic) of NT$3.05 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Gin Hwa Biotech and its competitors.
Is Gin Hwa Biotech's EPS (Basic) too high?
Gin Hwa Biotech's current EPS (Basic) is NT$3.05. Overall, Gin Hwa Biotech has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Gin Hwa Biotech's EPS (Basic) compare to VRTX and REGN?
Gin Hwa Biotech's EPS (Basic) of NT$3.05 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Gin Hwa Biotech and its competitors. Gin Hwa Biotech's current EPS (Basic) is NT$3.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gin Hwa Biotech stock overvalued right now?
Gin Hwa Biotech (ROCO:7806) has a current EPS (Basic) of NT$3.05. The current EPS (Basic) is NT$3.05. Gin Hwa Biotech's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Gin Hwa Biotech (ROCO:7806), the current EPS (Basic) is NT$3.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gin Hwa Biotech Business Description

Address No. 5, Guangming 7th Lane, Weixin Road, 1st Floor, Yong'an District, Kaohsiung, TWN, 828
Gin Hwa Biotech Inc is engaged in developing completely original products to achieve every vision. Its Services and technology are Product Development, OEM Service, Core Technology, R & D Center, Professional Production, and Others.
22GF Score

Get the complete analysis for ROCO:7806

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$61.90
Price